Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>Sinomenine (SIN) is clinically used as an anti-rheumatic drug. However, the metabolic and pharmacological mechanisms of SIN combined with its metabolites are unclear. This study aims to explore the cyclic metabolic mechanism of SIN, the anti-inflammation effects of SIN and its major metabolites (<em>N</em>-demethylsinomenine (DS) and sinomenine-<em>N</em>-oxide (SNO)), and the oxidation property of SNO.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>SIN was administrated to rats via gavage. Qishe pills (a SIN-containing drug) were orally administrated to humans. The bio-samples were collected to identify SIN's metabolites. Enzymatic and non-enzymatic incubations were used to reveal SIN's metabolic mechanism. Impacts of SIN, SNO and DS on the inflammation-related cytokine's levels and nuclear translocation of NF-κB were evaluated in LPS-induced Raw264.7 cells. ROS induced by SNO (10 μM) was also assessed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Key findings</h3><p>CYP3A4 and ROS predominantly mediated the formation of SNO, and CYP3A4 and CYP2C19 primarily mediated the formation of DS. Noteworthily, SNO underwent N-oxide reduction both enzymatically, by xanthine oxidase (XOD), and non-enzymatically, by ferrous ion and heme moiety. The levels of IL-6 and TNF-α and nuclear translocation of NF-κB were ameliorated after pretreatment of SIN in LPS-induced Raw264.7 cells, while limited attenuations were observed after pretreatment of DS (SNO) even at 200 μM. In contrast, SNO induced ROS production.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Significance</h3><p>This study elucidated that SIN underwent both enzymatic and non-enzymatic cyclic metabolism and worked as the predominant anti-inflammation compound, while SNO induced ROS production, suggesting more studies of SIN combined with SNO and DS are necessary in case of DDI and potential toxicities.</p>

Ph-Dependent, Stereoselective Dimerization Of Sinomenine

Β-Methyltryptamine Provoking the Crucial Role of Strictosidine Synthase Tyr151-OH for Its Stereoselective Pictet−Spengler Reactions to Tryptoline-type Alkaloids

Stereocomplementary Chemoenzymatic Pictet–Spengler Reactions for Formation of Rare Azepino-indole Frameworks: Discovery of Antimalarial Compounds

Biocatalyzed Cross-Coupling of Sinomenine and 1,2-Dihydroxybenzene by Coriolus Unicolor

Biocatalyzed cross-coupling of sinomenine and guaiacol by Antrodiella semisupina.

Induced biotransformation of sinomenine by o-phenylenediamine

Regio- and Stereoselective C-10 Beta-H Functionalization of Sinomenine: an Access to More Potent Immunomodulating Derivatives

Benign Synthesis Of Unsymmetrical Arylurea Derivatives Using 3-Substituted Dioxazolones As Isocyanate Surrogates

Synthesis and biological evaluation of unique stereodimers of sinomenine analogues as potential inhibitors of NO production

Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents.

Total Synthesis of Sinomendine and Its Analogs

Two New Morphinane Alkaloids from Sinomenium Acutum

Research progress in sinomenine structural modification

Metabolic mechanism and anti-inflammation effects of sinomenine and its major metabolites N-demethylsinomenine and sinomenine-N-oxide

Design, Synthesis, Biological Evaluation and Silico Prediction of Novel Sinomenine Derivatives.

Synthesis of Sinomenine's Derivatives and Their Analgesic and Anti-Inflammatory Quantitative Structure-Activity Relationships

Synthesis Of 1-Substituted Aminomethyl-7,8-Didehydro-4-Hydroxy-3,7-Dimethoxy-1 7-Methylmorphinan-6-One

Rapid Characterization of the Potential Active of Sinomenine in Rats by Ultra‐High‐Performance Liquid Chromatography‐Quadrupole‐Exactive Orbitrap Mass Spectrometry and Molecular Docking

Eleven undescribed alkaloids from the rhizomes of Sinomenium acutum and their IDO1 and TDO inhibitory activities

Microfluidics assisted synthesis and bioevaluation of sinomenine derivatives as antiinflammatory agents.

Anti-inflammatory Effects of Novel Sinomenine Derivatives.